Targeted drug improves survival in early-stage breast cancer
The results from the major phase III OlympiA trial shows the drug improves survival rates in women who have inherited faults in their BRCA1 or BRCA2 genes.
Mar 17, 2022
0
23
The results from the major phase III OlympiA trial shows the drug improves survival rates in women who have inherited faults in their BRCA1 or BRCA2 genes.
Mar 17, 2022
0
23
University of Otago-led research has identified a new rare genetic mutation which will finally give families around the world answers as to what is affecting their loved one.
Mar 9, 2022
0
24
Female astronauts could avoid knee injuries during space flight—and better tests, prevention and treatments could be developed for knee osteoarthritis in women here on Earth—based on newly published research on the sex ...
Mar 2, 2022
0
76
The most critical genes that cause coronary heart disease and trigger heart attacks have been identified in a major new study.
Feb 15, 2022
0
118
Following surgery, patients with breast cancer are faced with the question of whether additional chemotherapy is necessary and really effective. It is important that these women do not receive too much treatment—but not ...
Feb 11, 2022
0
48
By sequencing known genes associated with cardiac arrhythmia risk in more than 20,000 people without an indication for genetic testing, scientists were able to identify pathogenic and likely pathogenic variants in nearly ...
Feb 10, 2022
0
89
Researchers led by a team at Baylor College of Medicine have identified a novel neurodevelopmental disorder associated with mutations or deletions affecting a gene called PAX5. Their findings are published in the journal ...
Jan 31, 2022
0
31
As the demand soars for tests that can rapidly detect COVID-19, with pharmacies and grocery stores around the country selling out of tests as fast as they can be stocked, a UConn researcher aims to make home tests better ...
Jan 28, 2022
0
7
Scientists have developed a new machine learning model for the discovery of genetic risk factors for diseases such as Motor Neurone Disease (MND).
Jan 18, 2022
0
132
Access to the laboratory is strictly limited, for the risk of accidental infection is just too high.
Dec 9, 2021
0
4